KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.151 $0.151 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $0.120 $0.168
52 weeks $0.0471 $3.25

Historical Clovis Oncology prices

Date Open High Low Close Volume
Feb 25, 2016 $18.24 $18.57 $17.07 $17.29 1 158 600
Feb 24, 2016 $17.63 $18.24 $16.78 $18.08 804 400
Feb 23, 2016 $18.37 $18.37 $17.50 $17.63 686 400
Feb 22, 2016 $18.14 $18.39 $17.65 $18.26 986 300
Feb 19, 2016 $17.75 $18.39 $17.17 $17.92 741 700
Feb 18, 2016 $19.89 $20.12 $17.47 $17.81 1 229 400
Feb 17, 2016 $19.72 $20.45 $18.96 $19.86 1 100 400
Feb 16, 2016 $19.41 $19.82 $18.61 $19.46 936 500
Feb 12, 2016 $18.87 $19.18 $17.80 $18.97 1 294 100
Feb 11, 2016 $18.46 $19.05 $17.90 $18.60 620 300
Feb 10, 2016 $18.85 $20.80 $18.53 $18.98 995 800
Feb 09, 2016 $18.42 $19.50 $17.76 $18.56 601 800
Feb 08, 2016 $19.34 $19.47 $18.06 $18.81 768 700
Feb 05, 2016 $20.60 $20.98 $19.69 $19.87 613 400
Feb 04, 2016 $19.83 $22.05 $19.83 $20.55 759 900
Feb 03, 2016 $19.89 $20.34 $18.64 $20.08 1 039 100
Feb 02, 2016 $20.83 $20.84 $19.50 $19.79 783 000
Feb 01, 2016 $20.97 $21.29 $19.76 $20.90 1 132 900
Jan 29, 2016 $20.59 $21.69 $19.87 $20.92 962 500
Jan 28, 2016 $21.47 $21.99 $20.26 $20.63 818 500
Jan 27, 2016 $22.10 $22.46 $21.07 $21.26 884 500
Jan 26, 2016 $23.01 $23.39 $21.80 $22.39 1 039 300
Jan 25, 2016 $22.30 $24.18 $22.12 $22.99 1 576 900
Jan 22, 2016 $22.46 $22.75 $21.37 $22.55 1 199 200
Jan 21, 2016 $23.25 $23.46 $21.56 $21.71 1 112 400
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT